Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The miRNAs play critical roles in the progression of various tumors. Our study aimed to screen and identify miRNAs to investigate their diagnostic and prognostic value for papillary thyroid carcinoma (PTC).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>miRNAs were evaluated in PTC (<i>n</i> = 30) tissues, A-PTC (<i>n</i> = 30), benign nodules (<i>n</i> = 35) and A-benign nodules (<i>n</i> = 35). The expression levels of five miRNAs were quantified using real-time, quantitative PCR. ROC analysis was used to evaluate the miRNA diagnostic value. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The expression of miR-1296-5p, miR-1301-3p, and miR-532-5p was significantly downregulated (<i>p</i> = 0.0001, <i>p</i> = 0.0006, <i>p</i> = 0.0024, respectively), while miR-551b-3p and miR-455-3p were significantly upregulated in PTC tissues compared to A-PTC tissues (<i>p</i> = 0.0005, <i>p</i> = 0.0046, respectively). Interestingly, the expression of miR-1296-5p was downregulated, while miR-551b-3p and miR-455-3p were upregulated in the A-PTC group compared to the A-benign group. Moreover, the miR-1296-5p expression level was associated with tumor size, the number of foci and the TNM stage; the miR-455-3p expression level was correlated with patient age, tumor size, and TNM stage; and the miR-532-5p expression level was correlated with patient age, lymph node metastasis and TNM stage correspondingly. ROC analysis revealed that the AUCs for miR-1301-3p, miR-1296-5p, miR-455-3p, miR-532-5p, and miR-551b-3p were 0.773, 0.790, 0.783, 0.744, and 0.650, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our results indicated that miR-1296-5p, miR-1301-3p, miR-532-5p, miR-551b-3p, and miR-455-3p are aberrantly expressed in papillary thyroid carcinomas and correlated with clinicopathological features. ROC curve analysis indicated that these five miRNAs have a potential diagnostic value. Consequently, we speculate that the five altered miRNAs may serve as potential diagnostic and prognostic biomarkers for PTC.</p></section>

Expressions of Mirnas in Papillary Thyroid Carcinoma and Their Associations with the Braf(V600e) Mutation

Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer

Expression Profile And Clinical Significance Of Micrornas In Papillary Thyroid Carcinoma

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer with BRAF V600E Mutation.

Expressions of Mirnas in Papillary Thyroid Carcinoma and Their Associations with the BRAFV600E Mutation and Clinicopathological Features

Expression of Mirnas in Papillary Thyroid Carcinomas is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.

Associations of the BRAF V600E Mutation with Sonographic Features in Patients with Papillary Thyroid Carcinoma

Use of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules

Brafv600e Mutation in Papillary Thyroid Microcarcinoma: A Meta-Analysis

Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma.

BRAFV600E mutation and NIS expression in papillary thyroid carcinomas

Clinical Significance of BRAF Mutation and Expression in Papillary Thyroid Carcinoma

Expression Profiles of Micrornas and Their Target Genes in Papillary Thyroid Carcinoma

MicroRNA Profiling in Papillary Thyroid Cancer

Upregulation of Mir-2861 and Mir-451 Expression in Papillary Thyroid Carcinoma with Lymph Node Metastasis

The Combined Use Of Mirnas And Mrnas As Biomarkers For The Diagnosis Of Papillary Thyroid Carcinoma

BRAFV600E expression in papillary thyroid carcinoma: potential diagnostic utility

Mir-3619-3p Promotes Papillary Thyroid Carcinoma Progression Via Wnt/β-catenin Pathway

Role of Ultrasonographic Features and Quantified BRAFV600E Mutation in Lymph Node Metastasis in Chinese Patients with Papillary Thyroid Carcinoma

Aberrant expression of five miRNAs in papillary thyroid carcinomas

Integrated Analyses of Microrna and Mrna Expression Profiles in Aggressive Papillary Thyroid Carcinoma